SEOM Clinical Guidelines for the systemic treatment of early breast cancer 2013

The purpose of this article is to update our previous work on the treatment and follow-up in early breast cancer. In this new version we have classified a treatment by immunohistochemistry subtypes of breast cancer. Latest advances in the management of this disease have been compiled, either in the...

Full description

Saved in:
Bibliographic Details
Published inClinical & translational oncology Vol. 15; no. 12; pp. 1011 - 1017
Main Authors Del Barco, S., Ciruelos, E., Tusquets, I., Ruiz, M., Barnadas, A.
Format Journal Article
LanguageEnglish
Published Milan Springer Milan 01.12.2013
Subjects
Antineoplastic Agents, Hormonal - therapeutic use
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Breast Neoplasms - drug therapy
Breast Neoplasms - genetics
Breast Neoplasms - pathology
Chemotherapy, Adjuvant - standards
Clinical Guides in Oncology
Female
Genes, erbB-2
Humans
Medicine
Medicine & Public Health
Monitoring, Physiologic - standards
Neoadjuvant Therapy - standards
Neoplasm Staging
Oncology
Breast cancer
Follow-up guideline
Prognostics factors
Ending treatment
Adjuvant therapy
Guidelines
Online AccessGet full text

Cover

More Information
Summary:The purpose of this article is to update our previous work on the treatment and follow-up in early breast cancer. In this new version we have classified a treatment by immunohistochemistry subtypes of breast cancer. Latest advances in the management of this disease have been compiled, either in the adjuvant and neoadjuvant setting or chemotherapy and hormonal treatment. This review is presented in an easy way for oncologist, fellows and for other specialties.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Review-3
ObjectType-Feature-4
ObjectType-Instructional Material/Guideline-2
content type line 23
ISSN:1699-048X
1699-3055
DOI:10.1007/s12094-013-1084-3